Comparison Overview

Drug Interactions from The Medical Letter

VS

Warners Group Publications

Drug Interactions from The Medical Letter

145 Huguenot St, None, New Rochelle, New York, US, 10801
Last Update: 2025-11-27

Drug Interactions from The Medical Letter®—from the company you trust for unbiased drug information. Drug Interactions Are Preventable. With Drug Interactions from The Medical Letter®, clinicians can easily search for, quickly find, and prevent potentially life-threatening interactions between drugs. Some features of our new, continuously-updated database include: - Over 43,000 monographs describing interactions between prescription drugs, over-the-counter drugs, herbs, supplements, and lifestyle factors such as smoking and alcohol use - Trusted recommendations about how best to avoid or manage potential interactions - Information about whether other drugs in the same class or drugs used for the same indication could interact in a similar way - Intuitive online user interface that is optimized for delivery on your mobile device Subscribe to Drug Interactions from The Medical Letter - http://www.medicalletter.org/LIDIOE

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: None
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Warners Group Publications

The Maltings, Bourne, PE10 9PH, GB
Last Update: 2025-11-21

Your Trusted Partner in Publishing Success. For over 35 years, Warners Group Publications has been helping publishers grow with our comprehensive ‘Total Circulation’ service. From subscription and membership management to newstrade distribution, digital, and marketing services, we deliver tailored solutions that drive real results. As a highly successful family-run multimedia business, we own over 40 unique brands and support external clients with expert publishing services. With 170+ dedicated professionals working across seven divisions. We bring expertise and innovation, sharing our knowledge with clients to help them succeed in an evolving industry. Partner with us and take your publishing to the next level.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 174
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/drug-interactions-from-the-medical-letter.jpeg
Drug Interactions from The Medical Letter
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/warners-group-publications.jpeg
Warners Group Publications
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Drug Interactions from The Medical Letter
100%
Compliance Rate
0/4 Standards Verified
Warners Group Publications
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Drug Interactions from The Medical Letter in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Warners Group Publications in 2025.

Incident History — Drug Interactions from The Medical Letter (X = Date, Y = Severity)

Drug Interactions from The Medical Letter cyber incidents detection timeline including parent company and subsidiaries

Incident History — Warners Group Publications (X = Date, Y = Severity)

Warners Group Publications cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/drug-interactions-from-the-medical-letter.jpeg
Drug Interactions from The Medical Letter
Incidents

No Incident

https://images.rankiteo.com/companyimages/warners-group-publications.jpeg
Warners Group Publications
Incidents

No Incident

FAQ

Both Drug Interactions from The Medical Letter company and Warners Group Publications company demonstrate a comparable AI Cybersecurity Score, with strong governance and monitoring frameworks in place.

Historically, Warners Group Publications company has disclosed a higher number of cyber incidents compared to Drug Interactions from The Medical Letter company.

In the current year, Warners Group Publications company and Drug Interactions from The Medical Letter company have not reported any cyber incidents.

Neither Warners Group Publications company nor Drug Interactions from The Medical Letter company has reported experiencing a ransomware attack publicly.

Neither Warners Group Publications company nor Drug Interactions from The Medical Letter company has reported experiencing a data breach publicly.

Neither Warners Group Publications company nor Drug Interactions from The Medical Letter company has reported experiencing targeted cyberattacks publicly.

Neither Drug Interactions from The Medical Letter company nor Warners Group Publications company has reported experiencing or disclosing vulnerabilities publicly.

Neither Drug Interactions from The Medical Letter nor Warners Group Publications holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Drug Interactions from The Medical Letter company nor Warners Group Publications company has publicly disclosed detailed information about the number of their subsidiaries.

Neither Drug Interactions from The Medical Letter nor Warners Group Publications holds SOC 2 Type 1 certification.

Neither Drug Interactions from The Medical Letter nor Warners Group Publications holds SOC 2 Type 2 certification.

Neither Drug Interactions from The Medical Letter nor Warners Group Publications holds ISO 27001 certification.

Neither Drug Interactions from The Medical Letter nor Warners Group Publications holds PCI DSS certification.

Neither Drug Interactions from The Medical Letter nor Warners Group Publications holds HIPAA certification.

Neither Drug Interactions from The Medical Letter nor Warners Group Publications holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.